Altius Minerals Corp T.ALS

Alternate Symbol(s): ATUSF

Metals & Mining Industrial Metals & Minerals

Altius Minerals Corporation is a mineral royalty, renewable energy royalty and mineral project generation company. The Company holds royalty interests in approximately 12 operating mines located across Canada and Brazil that produces copper, zinc, nickel, cobalt, potash, iron ore and thermal (electrical) coal. Its segments include Mineral Royalties, Project Generation and Renewable Royalties. Its Mineral Royalties segment consists of the acquisition and management of producing and development stage royalty and streaming interests. Its Project Generation segment consists of acquisition and early-stage exploration of mineral resource properties with a goal of vending the properties to third parties in exchange for early-stage royalties and minority equity or project interests. Its Renewable Royalties segments consists of majority interest holding in Altius Renewable Royalties Corp (ARR), which is focused on the acquisition and management of renewable energy investments and royalties.

TSX:ALS - Post by User

Altius Minerals Corp

Bullboard Posts

Post by droid8805on Jan 17, 2008 1:55pm

259 Views

Post# 14219422

CVRD Hydromet plant EIS

The Long Harbour hydrometallurgical plant that CVRD wants to build needs a revised EIS. A shorter term delay plays in our favour as it reduces competition for labour and raw materials in Placentia Bay. It would be ideal if the refinery gets built followed immediately by the CVRD plant. I have no doubt that the large scale projects will be staggered in this fashion and the further ahead we remain in the race ensures we get built first. It also shows the superior work put in by the team at NLRC. The refinery was registered a full seven months after the hydromet plant and we are now ahead in the race. Keep up the good work boys, 24th of Jan is right around the corner. Cheers, Droid.
Here`s the link:
https://www.env.gov.nl.ca/env/Env/EA%202001/Bulletins%202008/20080116.pdf

Bullboard Posts

NervGen: Are amazing human trial results leaking out?